Oxazer-100

Oxaliplatin Injection IP

Enquire NOW!




Description

Description

Oxazer-100

Composition: Oxaliplatin 100mg /50 ml

Classification: Anticancer

Oxazer: Widely Prescribed, Trusted Globally

Oxazer is a highly prescribed anticancer medicine worldwide. Oncologists trust the brand for its premium quality and assured therapeutic efficacy.

Aprazer: A Global Name in Oncology Medicine

Aprazer Healthcare manufactures world-standard anticancer medicines, accepted and demanded globally.

  • • WHO-GMP certified
  • • Assured therapeutic efficacy and quality
  • • Available in 50+ countries

What is Oxazer?

Oxazer is widely accepted and used primarily for colorectal cancer and other solid tumors.

Uses of Oxazer

  • • Colorectal cancer
  • • Adjuvant therapy after surgery for advanced-stage colon cancer
  • • Gastrointestinal cancers
  • • Solid tumors

How does it work?

It prevents DNA replication and division, causing cancer cell death.

Common side effects

  • • Low platelets
  • • Increased risk of infections
  • • GIT upset – Nausea, diarrhea
  • • Mouth ulcers
  • • Numbness and tingling in hands and feet

Serious side effects

  • • Liver toxicity
  • • Severe infection
  • • Changes in urine output
  • • Severe dehydration and diarrhea
  • • Peripheral neuropathy

Precautions

To be used cautiously in patients with –

  • • Pre-existing liver disorders
  • • Bleeding disorders
  • • Low platelet count
  • • Kidney disorders
  • • Pre-existing nerve damage
  • • Low calcium and magnesium levels

Contraindications

  • • Not to be used if any previous allergy or hypersensitivity to Oxaliplatin or any excipients.
  • • Breastfeeding mothers
  • • Pregnant women

Warnings

To be used under the supervision of a medical practitioner or oncology specialist, having adequate diagnostic and monitoring facilities.

Important safety and monitoring information

Regularly monitor blood count, hepatic, manage infection risks, signs of neuropathy, and renal functions.

Storage

It should be stored at 2-8 degrees Celsius, protected from light.

Administration Instructions

  • • To be administered as a slow IV infusion (1–6 hours)
  • • To be used immediately after reconstitution.
Download Product PDF Attachment